Abstract
The CYP19 gene codes for the aromatase enzyme that is involved in the synthesis of oestrogens. This case–control study examines the relationship between a tetranucleotide repeat sequence in the CYP19 gene and the development of male breast cancer. No significant differences were found between male breast cancer cases and controls. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Jackson AW, Muldal S, Ockey CH and O'Connor PJ (1965) Carcinoma of the male breast in association with the Klinefelter syndrome. Br Med J 1: 223–225
Kristensen VN, Andersen TI, Lindblom A, Erikstein B, Magnus P and Børresen-Dale A-L (1998) A rare CYP19 (aromatase) variant may increase the risk of breast cancer. Pharmacogenetics 8: 43–48
Kurosaki K, Saitoh H, Oota H, Watanabe Y, Kiuchi M and Ueda S (1997) Combined polymorphism associated with a 3-bp deletion in the 5′-flanking region of a tetrameric short tandem repeat at the CYP19 locus. Nippon Hoigaku Zasshi 51: 191–195
Means GD, Mahendroo MS, Corbin CJ, Mathis JM, Powell FE, Mendelson CR and Simpson ER (1989) Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J Biol Chem 264: 19385–19389
Polymeropoulos MH, Xiao H, Rath DS and Merril CR (1991) Tetranucleotide repeat polymorphism at the human aromatase cytochrome P-450 gene (CYP19). Nucleic Acids Res 19: 195
Sasano H, Kimura M, Shizawa S, Kimura N and Nagura H (1996) Aromatase and steroid receptors in gynaecomastia and male breast carcinoma: an immunohistochemical study. J Clin Endocrinol Metab 81: 3063–3067
Siegelmann-Danieli, and Buetow KH (1999) Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk. Br J Cancer 79: 456–463
Young IE, Kurian KM, Annink C, Kunkler IH, Anderson VA, Cohen BB, Hooper ML, Wyllie AH and Steel CM (1999) A polymorphism in the CYP17 gene is associated with male breast cancer. Br J Cancer 81: 141–143
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Young, I., Kurian, K., MacKenzie, M. et al. A polymorphic tetranucleotide repeat in the CYP19 gene and male breast cancer. Br J Cancer 82, 1247–1248 (2000). https://doi.org/10.1054/bjoc.1999.1085
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.1999.1085
